Neos Therapeutics (NEOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,363 | -7,600 | -51,675 | -42,338 | -29,643 |
| Depreciation Amortization | 2,797 | 1,508 | 4,317 | 3,112 | 2,040 |
| Accounts receivable | 7,657 | 4,579 | -14,130 | -6,667 | -4,306 |
| Accounts payable and accrued liabilities | -6,174 | -4,178 | 1,270 | -3,957 | -5,400 |
| Other Working Capital | -486 | -755 | 2,935 | 504 | 4,748 |
| Other Operating Activity | -291 | 343 | 15,842 | 13,164 | 11,364 |
| Operating Cash Flow | $-7,860 | $-6,103 | $-41,441 | $-36,182 | $-21,197 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -4,435 | -7,190 | 18,585 | 18,585 | 8,839 |
| PPE Investments | -365 | -167 | -1,361 | -1,028 | -814 |
| Purchase Sale Intangibles | -55 | -18 | -5 | 3 | -28 |
| Other Investing Activity | -55 | -18 | -5 | 3 | -28 |
| Investing Cash Flow | $-4,855 | $-7,375 | $17,219 | $17,560 | $7,997 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -8,015 | -250 | -8,425 | -684 | -451 |
| Common Stock Issued | 11 | 11 | 47,292 | 3,892 | N/A |
| Other Financing Activity | -2 | -1 | -136 | 0 | 0 |
| Financing Cash Flow | $-8,006 | $-240 | $38,731 | $3,208 | $-451 |
| Beginning Cash Position | 46,478 | 46,478 | 31,969 | 31,969 | 31,969 |
| End Cash Position | 25,757 | 32,760 | 46,478 | 16,555 | 18,318 |
| Net Cash Flow | $-20,721 | $-13,718 | $14,509 | $-15,414 | $-13,651 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,860 | -6,103 | -41,441 | -36,182 | -21,197 |
| Capital Expenditure | -365 | -167 | -1,361 | -1,028 | -814 |
| Free Cash Flow | -8,225 | -6,270 | -42,802 | -37,210 | -22,011 |